Antecedents of organizational commitment of insurance agents: Job satisfaction, ethical behavior, and ethical climate

by Weihui Fu, Feng He, Na Zhang
Published 2020-09-01

A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19

by Yan Liu, Yan Liu, Guanxing Zhai, Weihui Fu, Xiaoyan Zhang, Xiaoyan Zhang, Jianqing Xu, Jianqing Xu
Published 2022-12-01

Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses

by Qimin Wang, Yuling Zhang, Peng Zou, Meixiang Wang, Weihui Fu, Jialei She, Zhigang Song, Jianqing Xu, Jinghe Huang, Fan Wu
Published 2020-08-01

Comparison of H7N9 and H9N2 influenza infections in mouse model unravels the importance of early innate immune response in host protection

by Cuisong Zhu, Cuisong Zhu, Miaomiao Zhang, Weihui Fu, Yongquan He, Yu Yang, Linxia Zhang, Songhua Yuan, Lang Jiang, Jianqing Xu, Jianqing Xu, Xiaoyan Zhang, Xiaoyan Zhang
Published 2022-08-01

CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells

by Linxia Zhang, Anli Zhang, Anli Zhang, Jun Xu, Chao Qiu, Lingyan Zhu, Chenli Qiu, Weihui Fu, Ying Wang, Lilin Ye, Yang-xin Fu, Chen Zhao, Xiaoyan Zhang, Jianqing Xu
Published 2020-09-01

Both haemagglutinin-specific antibody and T cell responses induced by a chimpanzee adenoviral vaccine confer protection against influenza H7N9 viral challenge

by Xiang Wang, Weihui Fu, Songhua Yuan, Xi Yang, Yufeng Song, Lulu Liu, Yudan Chi, Tao Cheng, Man Xing, Yan Zhang, Chao Zhang, Yong Yang, Caihong Zhu, Xiaoyan Zhang, Sidong Xiong, Jianqing Xu, Dongming Zhou
Published 2017-05-01

Seeking “protective” and “harmful” immune genes during chronic HIV-1 infection by transcriptome analysis

by Lingyan Zhu, PhD, Chao Qiu, PhD, Chenli Qiu, MS, Ying Wang, PhD, Yuan Dong, PhD, Linxia Zhang, PhD, Weihui Fu, PhD, Jun Wei, MS, Xiaoyan Zhang, MD, Jianqing Xu, MD
Published 2018-09-01

An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19

by Weihui Fu, Yan Liu, Li Liu, Huiliang Hu, Xiaobo Cheng, Ping Liu, Zhigang Song, Lijun Zha, Shimeng Bai, Tingting Xu, Songhua Yuan, Fengru Lu, Zhiying Shang, Yihong Zhao, Jing Wang, Jun Zhao, Longfei Ding, Jun Chen, Lin Zhang, Tongyu Zhu, Xiaoyan Zhang, Hongzhou Lu, Jianqing Xu
Published 2020-10-01

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

by Weihui Fu, Yan Liu, Lu Xia, Min Li, Zhigang Song, Huiliang Hu, Zongguo Yang, Lin Wang, Xiaobo Cheng, Mei Wang, Rongrong Jiang, Li Liu, Xiaoting Mao, Jun Chen, Yun Ling, Lin Zhang, Jin Yan, Fei Shan, Corklin Steinhart, Xiaoyan Zhang, Tongyu Zhu, Jianqing Xu, Hongzhou Lu
Published 2020-08-01

SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network

by Wei Li, Shuai Yang, Peng Xu, Dapeng Zhang, Ying Tong, Lu Chen, Ben Jia, Ang Li, Cheng Lian, Daoping Ru, Baolong Zhang, Mengxing Liu, Cancan Chen, Weihui Fu, Songhua Yuan, Chenjian Gu, Lu Wang, Wenxuan Li, Ying Liang, Zhicong Yang, Xiaoguang Ren, Shaoxuan Wang, Xiaoyan Zhang, Yuanlin Song, Youhua Xie, Hongzhou Lu, Jianqing Xu, Hailin Wang, Wenqiang Yu
Published 2022-02-01

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy

by Xiaoniu Miao, Yi Luo, Xi Huang, Suki M. Y. Lee, Zhijun Yuan, Yongzhou Tang, Liandi Chen, Chao Wang, Fan Wu, Yifeng Xu, Wenchao Jiang, Wei Gao, Xuedong Song, Yao Yan, Tuling Pang, Cheng Chen, Yuefeng Zou, Weihui Fu, Liping Wan, Javier Gilbert-Jaramillo, Michael Knight, Tiong Kit Tan, Pramila Rijal, Alain Townsend, Joanne Sun, Xiaolin Liu, William James, Andy Tsun, Yingda Xu
Published 2020-01-01

Weihui fu zhi : 53 juan, juan shou : 1 juan, juan mo : 1 juan /

by 880-01 De, Chang.
Published Qian